Aquestive Therapeutics Inc. Common Stock (NASDAQ: AQST)
Company Name:Aquestive Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: AQST
Class Period Start:08/07/2019
Class Period End (inclusive):09/25/2020
Filing Deadline:05/02/2021
According to the Complaint, Aquestive Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing various products to address unmet medical needs. The Company’s most advanced proprietary product candidate is Libervant (diazepam), a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures.